Medscape Alerts
- Alert Atypical Antipsychotic Linked to Life-Threatening Reactions
- Alert Eye Problems From Repackaged Bevacizumab
- Alert High Doses of SSRI Linked to Abnormal Heart Rhythm
- Alert Class I Recall of Arrow NextStep Hemodialysis Catheter
- Alert Jury Still Out on Somatropin and Increased Risk for Death
- Alert Multiple-Dose Vasopressin Vials Recalled Over Potency Issues
- Alert FDA Issues Class I Recall of Condenser Humidification Device
- Alert FDA Warns Against Fluconazole (Diflucan) in Early Pregnancy
- Alert Class I Recall of GEM Premier 4000 PAK Cartridges
- Alert FDA Warns Against Counterfeit Morning-After Pill
- Alert FDA: Avoid Methylene Blue or Linezolid With Serotonergics
- Alert FDA Studying Link Between Bisphosphonates, Esophageal Cancer
- Alert Single Lot of Calcium Gluconate Injection Recalled
- Alert FDA: Continuing Safety Concerns With Transvaginal Mesh
- Alert Lower Concentration for Oseltamivir Oral Suspension
- Alert FDA Reminds Clinicians About Risks With Belatacept
- Alert FDA Warns of Cognitive Delay in Offspring With Valproate
- Alert Recall of Pain, Headache Meds Because of Label Mix-Up
- Alert New Dosing Guidelines for Erythropoiesis-Stimulating Agents
- Alert Long-Term Complications Likely With Silicone Breast Implants